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The influence of binder type and process parameters on the compression properties and microbial 
survival in diclofenac tablet formulations were studied using a novel gum from Albizia zygia. Tablets 
were produced from diclofenac formulations containing corn starch, lactose and dicalcium phosphate. 
Formulations were analyzed using the Heckel and Kawakita plots. Determination of microbial viability 
in the formulations was done on the compressed tablets of both contaminated and uncontaminated tablets 
prepared from formulations. Direct compression imparted a higher plasticity on the materials than the 
wet granulation method. Tablets produced by wet granulation presented with a higher crushing strength 
than those produced by the direct compression method. Significantly higher microbial survival (p< 0.05) 
was obtained in formulations prepared by direct compression. The percent survival of Bacillus subtilis 
spores decreased with increase in binder concentration. The study showed that Albizia gum is capable 
of imparting higher plasticity on materials and exhibited a higher reduction of microbial contaminant 
in the formulations. The direct compression method produced tablets of reduced viability of microbial 
contaminant.
Uniterms: Tablets/production. Tablets/microbial analysis. Direct compression/tablets production. Wet 
granulation/tablets production. Tablets/microbial contamination. Microbial survival/in tablets. Albizia 
gum/use/tablets production. 
A influência do tipo de ligante e os parâmetros do processo de propriedades de compressão e sobrevivência 
microbiana em comprimidos de diclofenaco foram estudados utilizando uma nova goma de Albizia zygia. 
Os comprimidos foram produzidos a partir de formulações de diclofenaco contendo amido de milho, 
lactose e fosfato bicálcico. As formulações foram analisadas usando os gráficos de Heckel e Kawakita. 
A determinação da viabilidade microbiana nas formulações foi feita nos comprimidos contaminados e 
não contaminados preparados a partir de formulações. A compressão direta confere maior plasticidade 
dos materiais do que o método de granulação úmida. Comprimidos produzidos por granulação úmida 
apresentaram maior força de esmagamento do que aqueles produzidos pelo método de compressão 
direta. Observou-se sobrevivência significativamente maior (p<0,05) em formulações preparadas por 
compressão direta. A sobrevivência percentual dos esporos de Bacillus subtilis diminuiu com o aumento da 
concentração do agregante. O estudo mostrou que a goma de Albizia é capaz de conferir maior plasticidade 
aos materiais e apresentou maior redução da contaminação microbiana nas formulações. O método de 
compressão direta produziu comprimidos com viabilidade reduzida de contaminantes microbianos.
Unitermos: Comprimidos/produção. Comprimidos/análise microbiológica. Comprimidos/contaminação 
microbiana. Compressão direta/produção de comprimidos. Granulação úmida/produção de comprimidos. 
Sobrevivência microbiana/em comprimidos. Goma de Albizia/uso. 
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INTRODUCTION
Direct compression is highly efficient, less labori-
ous, and increasingly becoming more popular than both 
compression granulation and wet granulation methods in 
the manufacturing of tablets. However, few drug powders 
can be tabletted by the direct compression method, while 
most drugs need the incorporation of other substances 
referred to as tablet excipients in order to achieve sat-
isfactory properties such as strength, disintegration and 
dissolution times. One such excipient is the binding agent. 
Examples of binders include gelatin, polyvinylpyrrolidone 
(PVP), the cellulose derivatives (such as carboxyl meth-
ylcellulose) and pregelatinized starches. Binding agents 
employed in formulations are known to undergo a high 
degree of plastic deformation during compression and are 
forced into interparticulate spaces, where they increase 
the area of contact between the particles and form strong 
solid bonds (Itiola, Pilpel, 1991). The process of formation 
of these solid bonds is capable of exerting a lethal effect 
on microbial contaminants during tabletting (Ayorinde, 
Itiola, 2010).
Manufacturing processes have been known to pro-
duce a drop of about 70% in the viable count compared to 
the original raw materials of pharmaceutical products. The 
granulation step prior to tabletting often employs elevated 
temperatures (10-80 °C) for prolonged periods of time, and 
is known to destroy the vegetative forms of microorganism 
(Fry, Greaves, 1995). The shear stress manifested during 
compression depends largely on the principal mode of 
consolidation of the formulation, which can be either by 
fragmentation or plastic flow, with plastic flow having been 
shown to be a highly effective mechanism for microbial 
kill even at low compression pressures (Blair et al., 1991).
More than 15 different mathematical descriptions of 
the compaction process have been computed in the litera-
ture, and several of these, including those of Heckel and 
Kawakita and Ludde, have been validated for pharmaceu-
tical systems. In the present work, Heckel and Kawakita 
plots have been used to study the compressional behaviour 
of diclofenac with three different excipients. Also, the ef-
fects of different processing methods and binders on both 
the compressional properties and microbial survival in 
tablets have been studied.
Albizia gum is a gummy exudate from the trunk of 
the Albizia zygia tree (family Leguminosae). The tree is a 
well known tree in Africa and has wide distribution from 
Senegal in West Africa to east Africa, with no variation 
in term of quality of gum produced (World Agroforestry, 
2011). Albizia gum has superior binding properties than 
gelatin in tablet formulations (Odeku, 2005). Hence, this 
study seeks to investigate the effect of Albizia gum on sur-
vival of microbial contaminant and compare the mechani-
cal properties of diclofenac tablets containing Albizia gum 
with those containing gelatin as binding agents.
 Diclofenac, an important non-steroidal anti inflam-
matory drug (NSAID), was chosen in the present study due 
its poor compressibility. The formulation requires a binder, 
among other excipients, to form tablets of satisfactory 
mechanical strength. Bacillus subtilis, a spore-forming 
bacterium, was chosen as the microbial contaminant due 
to its resistance to destruction by both physical and chemi-
cal agents.
MATERIALS AND METHODS
The materials used in this work were diclofenac 
(Unique Chemicals, Gujarat, India), corn starch, dical-
cium phosphate (DCP) and lactose (Sam Pharmaceuti-
cals, Ilorin, Nigeria), Gelatin BP (Hopkins and Williams, 
Chadwell Health, Essex, UK), Bacillus subtilis spores 
(Laboratory stock culture, Department of Veterinary 
Microbiology and Parasitology, University of Ibadan), 
Nutrient agar pH 6.0, Nutrient broth pH 6.8, Sabouraud 
dextrose agar pH 5.6, MacConkey broth (Department of 
Pharmaceutical Microbiology, University of Ibadan.), and 
Albizia gum (from Albizia zygia tree, Botanical gardens, 
University of Ibadan).
Collection and Purification of Albizia zygia gum
The trunk of Albizia zygia tree was incised and the 
exudate was allowed to harden, after which it was collected 
from the tree. The hardened exudate was dried in a hot air 
oven at 40 oC until brittle, and then crushed to powder, using 
a mortar and pestle. The powder was further size-reduced 
by passing through an Osterizer blender (Model 857, Wil-
lamette Industries, Bowling Green, Kentucky, USA). The 
powdered gum was hydrated in double-strength chloroform 
water for 5 days with intermittent stirring. The resultant mu-
cilage was strained through a clean calico cloth to remove 
extraneous materials. The gum was then precipitated from 
solution with 95% v/v ethanol. The precipitated gum was 
filtered, washed with diethyl ether and then dried in hot air 
oven at 40 °C (Odeniyi and Jaiyeoba, 2009).
Preparation of inoculum
An overnight culture (18 h) was prepared from Ba-
cillus subtilis spores (Laboratory stock culture obtained 
from Department of Veterinary Microbiology and Parasi-
tology, University of Ibadan). One (1) mL of the overnight 
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culture was placed in 9 mL of sterile distilled water and 2 
mL of the culture was placed in sterile glass mortars and 
allowed to dry at 37 °C for 48 h.
Preparation of powder formulations
The binary mixtures of diclofenac and the excipients 
were prepared by mixing diclofenac and each of the ex-
cipient powders in the ratio of 1:1 (Sujja-areevath et al., 
1996). The formulations formed were: diclofenac formu-
lation containing corn starch (DCS), diclofenac formula-
tion containing lactose (DL) and diclofenac formulation 
containing dicalcium phosphate (DDCP). Each batch 
was mixed for 5 min in a Kenwood planetary mixer. The 
powder mixtures were then stored in airtight containers 
and labelled appropriately. The formulation components 
and process parameters are given in Table I.
Contamination of materials
Quantities (10 g) of the prepared diclofenac formula-
tions were gently mixed in the Bacillus subtilis-contami-
nated glass mortars by the method of increasing quantities 
(Plumpton et al., 1986) to give an even dispersion of the 
contaminating organism within the individual samples. 
Viable counts of microbial contaminants were carried out 
on the contaminated and uncontaminated materials.
Preparation of granules
Batches (250 g each) of diclofenac formulations 
containing diclofenac (50% w/w) + corn starch (50% w/w) 
(DCS), diclofenac (50% w/w) + lactose (50% w/w) (DL), 
and diclofenac (50% w/w) + DCP (50% w/w) (DDCP) 
were used.
Each formulation batch was dry-mixed for 5 min 
in a Kenwood planetary mixer and then moistened with 
either 30 mL of distilled water or appropriate quantities 
of mucilages and solutions of Albizia zygia gum and 
gelatin respectively, to give 1% or 4% w/w of the gum 
and gelatin in the final granule formulation. Massing was 
continued for 5 min and the wet masses were granulated 
by passing them manually through a number 12 mesh sieve 
(1400 μm). The granules produced were dried in a hot air 
oven for 18 h at 50 °C and thereafter re-sieved through a 
number 16 mesh sieve (100 μm). The granules were stored 
in airtight containers.
Preparation of tablets
Quantities (500 mg) of the powder and granule for-
mulations of contaminated and uncontaminated diclofenac 
formulations were compressed for 1 min into tablets with 
pre-determined loads, using a Carver hydraulic hand press 
(Model C, Carver Inc, Menomonee Falls, Wisconsin, 
USA), using a 12.5 mm die and flat-faced punches. Before 
each compression, the die and punches were lubricated 
with a 2% w/v dispersion of magnesium stearate in ether. 
After compression, tablets were stored in airtight contain-
ers for 24 h to allow for elastic recovery and hardening and 
to prevent falsely low yield values. The weights and di-
mensions of the tablets were determined to within ± 1 mg 
TABLE I - Formulation components and process parameters for diclofenac tablets
Formulation Components Binder Compression Process
DCSdc 50% Diclofenac + 50% Corn starch None Direct compression
DLdc 50% Diclofenac + 50% Lactose None Direct compression
DDCPdc 50% Diclofenac + 50% Dicalcium phosphate None Direct compression
DCSg 50% Diclofenac + 50% Corn starch Gelatin 
1% w/w and 4% w/w
Wet granulation
DLg 50% Diclofenac + 50% Lactose Gelatin 
1% w/w and 4% w/w
Wet granulation
DDCPgg 50% Diclofenac + 50% Dicalcium phosphate Gelatin 
1% w/w and 4% w/w
Wet granulation
DCSg 50% Diclofenac + 50% Corn starch Albizia gum 
1% w/w and 4% w/w
Wet granulation
DLg 50% Diclofenac + 50% Lactose Albizia gum 
1% w/w and 4% w/w
Wet granulation
DDCPg 50% Diclofenac + 50% Dicalcium phosphate Albizia gum 
1% w/w and 4% w/w
Wet granulation
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and 0.01 mm respectively. The relative densities (D) of 
the tablets were calculated using the following equation:
 D = W/Vt.ρs  (1)
where W = weight of tablet; D = relative density of the 
tablet; Vt = volume of the tablet, and ρs = Particle density 
of the material
Analysis of compressional properties
The compressional properties of diclofenac with the 
three different excipients were studied using Heckel and 
Kawakita equations.
Determination of viability
Viable counts were carried out on the compressed 
tablets of both contaminated and uncontaminated tablets 
prepared from powder and granule formulations. These 
were compared with the viable counts of uncompressed 
contaminated materials.
Approximately 1-g quantities of contaminated (or 
uncontaminated) tablets were disintegrated in 9 mL of 
sterile distilled water. The resultant suspension was seri-
ally diluted and 1 mL volume of the 1-in-100 dilution was 
transferred immediately into 10 mL melted and cooled 
nutrient agar. Using pour-plate method, the content of the 
nutrient agar bottle was transferred into the sterile Petri 
dish. The agar was allowed to set and then incubated 
at 37 °C for 24 h. Survival, estimated as the mean of 
quadruplicate determinations, was expressed for the con-
taminated tablets as a percentage relative to uncompressed 
control contaminated materials.
Tensile strength tests
The tensile strength of tablets was determined at 
room temperature by diametrical compression (Fell, 
Newton, 1970) using a tablet hardness tester, 400060, 
Model:EHHO1 (DBK Instrument, Mumbai, India). All 
measurements were made in quadruplicate.
RESULTS AND DISCUSSION
Compressional properties
Representative Heckel and Kawakita plots for 
diclofenac formulations are shown in Fig. 1 and Fig. 2 
respectively. High linearity with correlation coefficients 
of generally greater than 0.95 was obtained at the second 
phase of the plots, which generally commenced at the ap-
plied pressure of 113.230 MNm-2 for diclofenac formula-
tions. Such high linearity is often experienced with com-
paratively soft materials that undergo plastic deformation 
while retaining different degrees of porosity depending on 
the initial packing arrangement in the die. 
The mean yield pressure (Py), and the measure of 
the total amount of plastic deformation (Pk) occurring 
during compression, both of which are inverse plasticity 
parameters were derived from the Heckel and Kawakita 
plots respectively and were used in comparing the com-
pressional properties of the formulations. The values for 
these parameters are presented in Table II.
The mode of consolidation of diclofenac formu-
lations was found to be dependent on the nature of the 
excipient present in the formulation. Formulations con-
taining corn starch (DCS) deformed mainly by plastic 
flow, while formulations containing a fracturing excipient, 
DCP (DDCP), consolidated by fragmentation. Formula-
FIGURE 1 - Heckel plots for Diclofenac tablet formulations.
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TABLE II - Values of relative density of tablets at compression pressure of 113.23MNm-2 (D), Py and Pk for diclofenac formulations 
Formulation Compression Method Binder/Concentration D Py Pk
DCS
DCS
Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.853
0.855
0.858
0.867
0.863
0.874
32.258
105.263
103.093
83.333
78.125
64.103
0.205
0.217
0.208
0.165
0.187
0.082
DL
DL
Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.853
0.868
0.871
0.879
0.876
0.885
90.090
112.359
108.696
95.238
82.644
71.429
0.319
0.328
0.276
0.215
0.214
0.113
DDCP
DDCP
Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.856
0.878
0.882
0.890
0.889
0.894
92.592
312.500
294.118
158.730
217.391
163.934
0.370
0.441
0.399
0.278
0.264
0.159
FIGURE 2 - Kawakita plots for Diclofenac formulations.
tions containing lactose (DL) showed an initial curve at 
the early stage of compression, the curve became linear 
at the later stage. This showed that DL deformed by frag-
mentation at the early stage of compression, followed by 
plastic deformation at the later stage. These results show 
that the mode of consolidation of the drug, diclofenac, is 
largely dependent on the nature of the excipient used in 
the formulation.
Mean yield pressure (Py) and Pk
The yield pressure is defined as the stress at which 
plastic deformation of the particles commences and can 
be derived from the linear part of the Heckel plot while Pk 
is another pressure term which represents the pressure re-
quired to reduce the powder bed by 50% and is obtainable 
from Kawakita plots (Adams et al., 1994). Both Py and Pk 
have an inverse relationship with plasticity of materials.
DCS was found to have the least Py and Pk values. 
The ranking of Py and Pk values among diclofenac formula-
tions was DDCP > DL > DCS. The difference was signifi-
cant according to ANOVA (p < 0.05). This implies that the 
onset of plastic deformation occurred at lowest pressure 
in DCS. This suggests that corn starch as an excipient will 
induce faster onset and extent of plastic flow in diclofenac 
formulations than either lactose or DCP and that corn 
starch is able to increase the softness of the formulation 
and its ability to deform plastically under pressure more 
than lactose and DCP. 
The deformation mechanism of a specific particle 
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is affected mainly by the molecular and crystal structure 
of the material (Rasenack, Muller, 2002). Hard, brittle 
materials which have greater shear strength than tensile 
strength tend to fragment more easily than soft materials, 
which have lower shear strength than tensile strength. 
Particles also have a critical diameter at which the den-
sification mechanism turns from fragmentation to plastic 
deformation when particle size decreases (Roberts, Rowe, 
1996). This appears to be the case with DL in this study, 
in which the formulation fragmented at the early stage of 
the compression and exhibited plastic deformation at the 
later stage. 
The Py and Pk values for powder formulations pro-
duced by the direct compression method of tablet produc-
tion were lower than the values for the granule formula-
tions produced by the wet granulation method (with no 
binder). This is probably due to fragmentation of the gran-
ules at low pressures and subsequent filling of void spaces 
between the particles (Itiola, Pilpel, 1991). This therefore 
suggests that direct compression is capable of impart-
ing more plasticity to materials than the wet granulation 
method in tablet production. However, as binders were 
incorporated into the formulations in the wet granulation 
method, the Py values decreased and further decreased as 
binder concentration increased. This is in agreement with 
previous work (Alebiowu, Itiola, 2001), which reported 
that onset of plastic deformation in formulation occurred 
at lower pressures with increase in binder content. The Py 
and Pk values obtained for formulations containing Albizia 
gum were generally lower than those of formulations 
containing gelatin as binder (P<0.05). This suggests that 
Albizia gum as a binder has superior qualities over gelatin 
in improving the softness and plasticity of materials.
The differences between Py and Pk (Table II) values 
are probably due to the fact that, while Py relates essen-
tially to the onset of plastic deformation, Pk relates to the 
amount of plastic deformation occurring during the com-
pression process, especially with plastic deformation being 
a time dependent phenomenon (Oloniyon et al.,1998).
Tensile strength (T) of tablets
Bond strength is measurable by the tensile strength 
(T) of tablets (Itiola, Pilpel,1991; Fry, Greaves,1995). 
Tensile strength has been used in this present study to 
assess the mechanical properties of diclofenac tablets, in 
which the binding properties of gelatin and Albizia gum 
were compared.
The results of the tensile strength on diclofenac 
tablet formulations are presented in Table III, while the 
representative plots of log tensile strength versus relative 
density of tablets are shown in Figure 3. Correlation coef-
ficients of generally greater than 0.970 were obtained in 
all the formulations. This could be attributed to different 
types of forces that are acting between the constituent 
particles which include the interparticulate forces of at-
traction or van der Waals’ forces, mechanical interlocking 
and other forces that operate between particles as they 
are brought into closer contact between the particles. The 
greater the effective surface area of contact, the greater 
is the degree of bonding, and, in effect, the greater the 
tensile strength.
TABLE III - Granule properties of the formulations
Formulations Binder/concentration Mean granule size 
(µm)
Loose bulk density 
(g cm3)
Particle density  
(g cm3)
Relative density at 
zero pressure
DCS None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum,4%
605
650
710
800
850
0.297
0.308
0.340
0.345
0.372
1.456
1.455
1.454
1.454
1.453
0.204
0.212
0.234
0.237
0.256
DL None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
500
565
630
680
730
0.353
0.359
0.363
0.389
0.456
1.489
1.489
1.487
1.486
1.484
0.237
0.241
0.244
0.262
0.307
DDCP None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
440
480
560
610
650
0.398
0.430
0.433
0.480
0.505
2.166
2.165
2.164
2.163
2.160
0.184
0.199
0.200
0.222
0.234
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TABLE III - Values of Tensile strength (T) of diclofenac tablets at relative density of 0.900
Formulation Compression method Binder/Concentration Tensile strength, T (MN/m2)
DCS Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.312
0.318
0.384
0.781
0.605
0.988
DL Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.320
0.331
0.392
0.811
0.658
1.210
DDCP Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.328
0.375
0.404
0.881
0.683
1.410
FIGURE 3 - Representative plots of log tensile strength versus 
relative density for diclofenac formulations.
DDCP generally exhibited the highest values of T 
among diclofenac formulations. The ranking was DDCP > 
DL > DCS. This result shows that formulations contain-
ing fracturing materials produced tablets of higher tensile 
strength. Correlations have been found between fracture 
strength and compression behaviour of particles (Fichtner, 
2007). The deformability of pellets made of microcrystal-
line cellulose could be related to their tensile and shear 
strength, and was found to be reduced for stronger pellets 
(Bashaiwoldu et al., 2004). 
A higher crushing strength was obtained for granules 
(in tablets produced by wet granulation with no binder) 
than for powders of the same formulation (in tablets 
produced by direct compression method). This could be 
explained by the variation in the intra-granular or intra-
particle porosity. The higher bulk density of the powders 
is an indication of reduced intra-particle porosity, which 
might have led to tablets of higher crushing strength.
Upon incorporation of binders, the values of T were 
found to be higher in tablets containing Albizia gum than 
those containing gelatin as binder. This could be as a result 
of a higher amount of plastic deformation which occurred 
during the compression process in the formulation contain-
ing Albizia gum than those in which the binder used was 
gelatin. This is evidenced by low Py and Pk values obtained 
in the formulations containing Albizia gum.
Tablets containing Albizia gum exhibited higher 
values of T (p < 0.05) than those containing gelatin. It can 
therefore be inferred that Albizia gum could be more use-
ful as a binder than gelatin in tablet production. 
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Microbial survival during tabletting
Table IV shows the values of log percent survival 
with compression pressure in diclofenac formulations. 
Plots of log% survival of Bacillus subtilis spores in the 
tablets against compression pressure for diclofenac for-
mulations are shown in Figure 4.
An inverse linear relationship between log% surviv-
al and compression pressure with correlation coefficient 
of 0.956 to 0.996 was obtained in all the formulations 
with both types of binders and at all concentrations used. 
These correlations were significant (p < 0.05). Such linear 
relationship between log% survival of microorganisms and 
compression pressure has been reported for other pharma-
ceutical preparations in previous works (Rasenack, Muller, 
2002; Roberts, Rowe, 1996; Fichtner, 2007; Bashaiwoldu 
et al., 2004; Ayorinde et al., 2005).
DCS, the most plastic formulation as evidenced by 
the lowest values of both Py and Pk, was found to exhibit 
the highest reduction in viability of the microbial con-
taminant. The ranking of reduction of viability among 
diclofenac formulations was DCS > DL > DDCP. At a 
compression pressure of 226.46 MN/m2, DCS had a reduc-
tion of viability of 94%, DL had 90% while DDCP had 
88%. Plastic deformation which was the main mechanism 
of consolidation in DCS led to greater interparticulate 
contact, thereby enhancing greater mechanical disruption 
of the microorganisms than DL and DDCP formulations. 
Significantly (p < 0.05) higher microbial survival 
was obtained in powder formulations prepared by direct 
compression than in granule formulations prepared using 
TABLE IV - Values of Log% Survival of Bacillus subtilis Spores in Diclofenac Formulations at the Compression pressure of 226.46 
MN/m2
Formulation Compression Method Binder/Concentration Log% Survival
DCS Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
0.864
0.783
0.727
0.636
0.703
0.609
DL Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
1.000
0.930
0.883
0.860
0.830
0.809
DDCP Direct compression
Wet granulation
None
None
Gelatin, 1%
Gelatin, 4%
Albizia gum, 1%
Albizia gum, 4%
1.267
1.177
1.131
1.026
1.032
0.983
FIGURE 4 - Log% survival versus applied pressure, (p).
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the wet granulation method (with no binder). To form 
granules, bonds must be formed between powder particles 
so that they adhere, and these bonds must be sufficiently 
strong to prevent breakdown of the granules to powder in 
subsequent handling operations. These strong interparticu-
late bonds are capable of a lethal effect on microorganisms. 
It is known that granulation steps prior to compression 
into tablets often employ temperatures in excess of 50 °C 
and are therefore detrimental to microbial survival. Fry 
and Greaves (1995) reported that wet granulation led to a 
reduction in microbial contaminants.
The results further show that, in all the formulations, 
the percent survival of Bacillus subtilis spores decreased 
with increase in binder concentration and formulations 
containing Albizia gum exhibited a higher reduction of 
viability of the microbial contaminant than those contain-
ing gelatin. The difference was significant (p < 0.05). This 
suggests that Albizia zygia gum is capable of reducing the 
survival level of microbial contaminants in the formed 
tablets. 
CONCLUSION
The study showed that Albizia gum is capable of 
imparting higher plasticity and improving the softness of 
materials as evidenced by lower values of Py and Pk in the 
formulations containing Albizia gum than those contain-
ing gelatin. Tablets containing Albizia gum were found 
to possess higher tensile strength than those containing 
the synthetic binder gelatin, thus suggesting that using 
Albizia gum as binder in tablet formulations is capable 
of producing tablets of satisfactory mechanical strength. 
Furthermore, tablets prepared with Albizia gum showed 
a higher reduction of viability of Bacillus subtilis spores 
than those with gelatin. This therefore suggests that Albizia 
gum has a greater lethal effect on microbial contaminants 
than gelatin. 
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